-
1
Comparative evaluation of the efficacy of topical amlexanox 5% oral paste and triamcinolone acetonide 0.1% oral paste in the treatment of Recurrent Aphthous Stomatitis (RAS)
Published 2018-01-01Subjects: “…Amlexanox…”
Get full text
Article -
2
Amlexanox Exhibits Cardioprotective Effects in 5/6 Nephrectomized Rats
Published 2023-01-01Subjects: “…Amlexanox…”
Get full text
Article -
3
AMLEXANOX 5% SEBAGAI MODALITAS TERAPI STOMATITIS AFTOSA REKUREN TERKINI
Published 2015-07-01Subjects: Get full text
Article -
4
Assessment of efficacy of 5% topical amlexanox and 0.1% topical triamcinolone acetonide in management of recurrent aphthous stomatitis
Published 2020-01-01Subjects: “…amlexanox…”
Get full text
Article -
5
Targeting TANK-binding kinase 1 attenuates painful diabetic neuropathy via inhibiting microglia pyroptosis
Published 2024-07-01Subjects: Get full text
Article -
6
Translational readthrough of ciliopathy genes BBS2 and ALMS1 restores protein, ciliogenesis and function in patient fibroblasts
Published 2021-08-01Subjects: Get full text
Article -
7
-
8
A clinical evaluation of 5% amlexanox oral paste in the treatment of minor recurrent aphthous ulcers and comparison with the placebo paste: A randomized, vehicle controlled, parall...
Published 2013-01-01Subjects: “…Amlexanox oral paste…”
Get full text
Article -
9
Amlexanox reduces new-onset atrial fibrillation risk in sepsis by downregulating S100A12: a Mendelian randomization study
Published 2024-10-01Subjects: Get full text
Article -
10
Acute TBK1/IKK-ε Inhibition Enhances the Generation of Disease-Associated Microglia-Like Phenotype Upon Cortical Stab-Wound Injury
Published 2021-07-01Subjects: Get full text
Article -
11
Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses
Published 2019-03-01Subjects: “…Amlexanox…”
Get full text
Article -
12
Amlexanox and Forskolin Prevents Isoproterenol-Induced Cardiomyopathy by Subduing Cardiomyocyte Hypertrophy and Maladaptive Inflammatory Responses
Published 2021-09-01Subjects: Get full text
Article -
13
-
14
-
15
Identification and Characterization of Amlexanox as a G Protein-Coupled Receptor Kinase 5 Inhibitor
Published 2014-10-01Subjects: Get full text
Article -
16
Restoration of functional PAX6 in aniridia patient iPSC-derived ocular tissue models using repurposed nonsense suppression drugs
Published 2023-09-01Subjects: Get full text
Article -
17
Comparative evaluation of the efficacy of topical Amlexanox 5%, Triamcinolone Acetonide 0.1%, and Tacrolimus 0.03% in the treatment of oral erosive lichen planus – A double-blinded...
Published 2022-01-01Subjects: “…amlexanox…”
Get full text
Article -
18
Comparative assessment of low-level laser therapy (LLLT) vs. topical application of amlexanox + lidocaine to treat recurrent aphthous ulcers (RAUs): A randomized controlled trial
Published 2021-02-01Subjects: “…amlexanox and lidocaine…”
Get full text
Article -
19
Inhibition of TBK1/IKKε Promotes Regeneration of Pancreatic β-cells
Published 2018-10-01Subjects: Get full text
Article -
20
Role of IKKε in the Metabolic Diseases: Physiology, Pathophysiology, and Pharmacology
Published 2022-05-01Subjects: Get full text
Article